Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.
Zhao J, Dinkel J, Warth A, Penzel R, Reinmuth N, Schnabel P, Muley T, Meister M, Zabeck H, Steins M, Yang JY, Zhou Q, Schlemmer HP, Herth FJF, Kauczor HU, Heussel CP. Zhao J, et al. Among authors: zabeck h. PLoS One. 2017 Sep 26;12(9):e0182741. doi: 10.1371/journal.pone.0182741. eCollection 2017. PLoS One. 2017. PMID: 28949965 Free PMC article.
Targeting LINC00673 expression triggers cellular senescence in lung cancer.
Roth A, Boulay K, Groß M, Polycarpou-Schwarz M, Mallette FA, Regnier M, Bida O, Ginsberg D, Warth A, Schnabel PA, Muley T, Meister M, Zabeck H, Hoffmann H, Diederichs S. Roth A, et al. Among authors: zabeck h. RNA Biol. 2018;15(12):1499-1511. doi: 10.1080/15476286.2018.1553481. Epub 2018 Dec 7. RNA Biol. 2018. PMID: 30499379 Free PMC article.
[Solitary pulmonary nodule in a patient with osteosarcoma of the right humerus].
Csernus R, Grigaliunas G, Zabeck H, Sumkauskaite M, Gődény M, Radeleff B, Kauczor HU, Heußel CP. Csernus R, et al. Among authors: zabeck h. Med Klin Intensivmed Notfmed. 2017 Feb;112(1):47-49. doi: 10.1007/s00063-016-0184-6. Epub 2016 Jun 17. Med Klin Intensivmed Notfmed. 2017. PMID: 27315069 German. No abstract available.
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
Kreuter M, Vansteenkiste J, Fischer JR, Eberhardt WE, Zabeck H, Kollmeier J, Serke M, Frickhofen N, Reck M, Engel-Riedel W, Neumann S, Thomeer M, Schumann C, De Leyn P, Graeter T, Stamatis G, Griesinger F, Thomas M; TREAT investigators. Kreuter M, et al. Among authors: zabeck h. J Thorac Oncol. 2016 Jan;11(1):85-93. doi: 10.1016/j.jtho.2015.09.014. J Thorac Oncol. 2016. PMID: 26762743 Free article. Clinical Trial.
12 results